Risk for Myocarditis, Myopericarditis After COVID-19 Vaccination
Researchers conducted a study to assess the association between SARS-CoV-2 vaccination and the risk for myocarditis or myopericarditis
Cardiovascular Disease
Efficacy and Safety of Statin Therapy in Patients with Hospital Admission for COVID-19
Researchers analyzed the risk between statin use and risk of mortality among patients hospitalized with COVID-19 in a study presented at AHA 2021.
Unique Risks in People With Familial Hypercholesterolemia and COVID-19
People with familial hypercholesterolemia with COVID-19 risk endothelial dysfunction. Therapy should continue during the course of the virus.
Early Treatment With Sotrovimab Decreases Risk for Progression to Severe COVID-19
Researchers conducted a study to determine whether treatment with sotrovimab decreases the risk for severe disease progression among high-risk patients with mild-to-moderate COVID-19.
Effects of Casirivimab/Imdevimab Treatment in High-Risk Patients With COVID-19
Researchers conducted a study that assessed the effects of casirivimab/imdevimab combination treatment on the risk for COVID-19-related hospitalization or death among outpatients at increased risk for severe SARS-CoV-2 infection.
Do At-Home Monoclonal Antibody Infusions Decrease the Risk for Hospitalization in High-Risk Patients With COVID-19?
Researchers conducted a study to assess whether an at-home neutralizing monoclonal antibody infusion program decreases the risk for hospitalization among patients with SARS-CoV-2 infection at increased risk for progression to severe disease.
Antithrombotic Therapy Not Helpful for COVID-19 Outpatients
Major adverse cardiopulmonary outcomes not reduced with aspirin, apixaban versus placebo for clinically stable COVID-19 outpatients.
Survival Outcomes in Patients With Severe COVID-19: Moderate- vs High-Dose Corticosteroids
Researchers conducted a study to determine the optimal corticosteroid dosing regimen for the treatment of patients hospitalized with severe COVID-19.
Optimal Time Identified for Monoclonal Antibody Infusions in Patients With COVID-19
Researchers sough to assess the effects of treatment with a monoclonal antibody infusion in patients hospitalized with COVID-19.
Safety, Tolerability, Immunogenicity of the Novel Pneumococcal Conjugate Vaccine V114 in Patients at Risk for Pneumococcal Disease
Researchers sought to assess the safety, tolerability, and immunogenicity of a novel pneumococcal conjugate vaccine (V114) in patients at risk for pneumococcal disease.
- Loading...
Loading...
Next post in ID Week 2021
Loading... 
Loading...